Grifols (GIKLY) Net Income (QoQ) (2010 - 2020)
Grifols (GIKLY) Net Income (QoQ) (2010 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn |
| 10 | Grifols | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -55.46% |
| Mar 31, 2019 | -75.72% |
| Jun 30, 2018 | -1.36% |
| Mar 31, 2018 | -70.06% |
| Jun 30, 2017 | 2.91% |
| Mar 31, 2017 | 344.94% |
| Dec 31, 2016 | -144.40% |
| Sep 30, 2016 | 12.39% |
| Jun 30, 2016 | -38.01% |
| Mar 31, 2016 | 127.99% |
| Dec 31, 2015 | -36.92% |
| Sep 30, 2015 | 5.68% |
| Jun 30, 2015 | -2.67% |
| Sep 30, 2013 | -5.76% |
| Jun 30, 2013 | 6.55% |
| Mar 31, 2013 | 11.61% |
| Dec 31, 2012 | 89.11% |
| Sep 30, 2012 | -55.48% |
| Jun 30, 2012 | -2.91% |
| Mar 31, 2012 | -45.57% |